ZED.TO
ZED.TO[1] was an alternate reality game run in Toronto in 2012. Players assumed roles as interns and employees in a fictional and futuristic biotechnology corporation called ByoLogyc,[2] and experienced the company's rise and disastrous fall first-hand through social media, online videos and websites, and live-action immersive theatrical events.
ZED.TO was produced by Toronto design collective The Mission Business;[3] founded by Elenna Mosoff, Trevor Haldenby, Martha Haldenby, David Fono, and Byron Laviolette and was crowdfunded on indiegogo in 2012.[4]
Recognition[edit]
ZED.TO won the inaugural Performance Innovation Award at the 2012 Toronto Fringe Festival,[5] as well as Best In Show at the 2012 World Future Society Beta Launch competition,[6] Best in Biological Design at Autodesk University,[7] and Best in Cross-Platform Fiction at the 2012 Digi Awards.[8]
Cast[edit]
- Andrew Moyes - Chet Getram
- Liam Toshio Morris - Davian Baxter
- Karen Donald - Bernice Hammersmith
- Emily Schooley - Dahlia Joss
- James Fanizza - Tyler Wyatt
- Janet Kish - Rentata Reinger
- Caitlin B. Driscoll - Marie LeClerc
- Kwan Ho Tse - Henry Chan
- Burton Wright - Brad Mitchell
- Ariana Leask - Adrian Quinn
- Shane Hollon - Dennis Kirkham
- Martha Haldenby - Olive Swift
- Adam Barrett - Paul Fischer
- Jennifer Walls - Felicity Chapman
References[edit]
- ^ "ZED.TO". The Mission Business. Retrieved 2 January 2013.
- ^ "ByoLogyc Corporate Website". ByoLogyc. Retrieved 2 January 2013.
- ^ "The Mission Business". The Mission Business. Retrieved 2 January 2013.
- ^ "IndieGoGo - ZED.TO". 2012. Retrieved 20 June 2015.
- ^ "awards, best of the fringe, best of fringekids! & patron's pick". Toronto Fringe Festival. Retrieved 2 January 2013.
- ^ Tucker, Patrick. "Innovators Go on Display at Futurists: BetaLaunch 2012". World Future Society 2012 Conference Review. World Future Society.
- ^ "Autodesk University 2012: How the Masters Create in 2025". Autodesk. Retrieved 2 January 2013.
- ^ "2012 Digi Awards - Winners Circle". Digi Awards. Retrieved 2 January 2013.